HOME•CIPLA•NSE

Cipla Limited

₹1451.20

1.43%

-₹21.10 Today

07 Jul 2026, 15:30:00 IST • INR • NSE • Disclaimer

Loading chart data...

Related Stocks

ABBOTINDIA

Abbott India Limited

₹26,700.00

0.60%

AJANTPHARM

Ajanta Pharma Limited

₹3,315.00

1.73%

AKUMS

Akums Drugs and Pharmaceuticals Limited

₹653.45

4.63%

ALIVUS

Alivus Life Sciences Ltd

₹1,143.00

0.65%

ALKEM

Alkem Laboratories Limited

₹5,662.00

1.13%

APLLTD

Alembic Pharmaceuticals Limited

₹831.00

0.56%

APOLLOHOSP

Apollo Hospitals Enterprise Limited

₹8,830.00

0.66%

ASTERDM

Aster DM Healthcare Limited

₹789.80

0.22%

ASTRAZEN

AstraZeneca Pharma India Limited

₹8,344.00

1.31%

AUROPHARMA

Aurobindo Pharma Limited

₹1,583.00

0.73%

StockIN Listed Security

PREVIOUS CLOSE₹1472.30

OPEN₹1472.30

DAY RANGE₹1449.20 - ₹1482.00

YEAR RANGE₹1165.70 - ₹1673.00

MARKET CAP₹ 0 Cr

DAY VOLUME1,164,880

P/E RATIO30.24

EPS48.00

PRIMARY EXCHANGENSE

About

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

Market Cap

117234.54

Total market value of outstanding shares.

EPS

48.00

Company's profit divided by outstanding shares.

P/E Ratio

30.24

Ratio of share price to its earnings per share.

805667520.00

Total number of outstanding shares.

1-Month High

1490.10

Highest price reached in the last 30 days.

1-Month Low

1346.60

Lowest price reached in the last 30 days.

52-Week High

1673.00

Highest price reached in the last year.

52-Week Low

1165.70

Lowest price reached in the last year.

Financial Statements - CIPLA

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Sales	5,520	5,479	5,260	5,375	5,829	5,810	5,739	6,329	6,678	6,604	6,163	6,694	7,051
Expenses	4,294	4,248	4,511	4,232	4,526	4,403	4,566	4,835	4,944	4,856	4,847	4,978	5,165
Operating Profit	1,226	1,231	750	1,143	1,302	1,408	1,174	1,494	1,734	1,748	1,316	1,716	1,886
OPM %	22%	22%	14%	21%	22%	24%	20%	24%	26%	26%	21%	26%	27%
Other Income	61	91	7	103	123	114	-48	136	176	-10	249	160	191
Interest	38	21	18	18	26	32	34	16	26	30	18	18	15
Depreciation	253	247	290	254	299	272	346	239	290	233	288	247	272
Profit before tax	996	1,054	448	975	1,100	1,218	745	1,375	1,594	1,474	1,259	1,611	1,789
Tax %	28%	28%	16%	28%	28%	34%	30%	28%	28%	28%	26%	27%	27%
Net Profit	709	757	371	706	797	808	522	998	1,155	1,068	932	1,175	1,305
EPS in Rs	8.82	9.03	4.49	8.51	9.78	9.92	6.51	12.33	14.01	13.08	11.63	14.58	16.13

Financial Statements - CIPLA

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Sales	5,520	5,479	5,260	5,375	5,829	5,810	5,739	6,329	6,678	6,604	6,163	6,694	7,051
Expenses	4,294	4,248	4,511	4,232	4,526	4,403	4,566	4,835	4,944	4,856	4,847	4,978	5,165
Operating Profit	1,226	1,231	750	1,143	1,302	1,408	1,174	1,494	1,734	1,748	1,316	1,716	1,886
OPM %	22%	22%	14%	21%	22%	24%	20%	24%	26%	26%	21%	26%	27%
Other Income	61	91	7	103	123	114	-48	136	176	-10	249	160	191
Interest	38	21	18	18	26	32	34	16	26	30	18	18	15
Depreciation	253	247	290	254	299	272	346	239	290	233	288	247	272
Profit before tax	996	1,054	448	975	1,100	1,218	745	1,375	1,594	1,474	1,259	1,611	1,789
Tax %	28%	28%	16%	28%	28%	34%	30%	28%	28%	28%	26%	27%	27%
Net Profit	709	757	371	706	797	808	522	998	1,155	1,068	932	1,175	1,305
EPS in Rs	8.82	9.03	4.49	8.51	9.78	9.92	6.51	12.33	14.01	13.08	11.63	14.58	16.13